Ontology highlight
ABSTRACT: Goals and background
Inflammatory bowel disease (IBD) serology testing is often used in patients with indeterminate colitis (IC) to help distinguish between ulcerative colitis (UC) and Crohn's disease (CD). We investigated the performance of serology testing in predicting future diagnosis in this setting.Study
This was an observational study of individuals with IC at a single center who underwent IBD serology testing [anti-Saccharomyces cerevisiae antibody (ASCA), perinuclear anti-neutrophil cytoplasmic antibody (pANCA), and anti-outer membrane porin C antibody (anti-OmpC)] and had at least 12 months follow-up from the time of serology test results.Results
A total of 117 individuals with IC and with 1-year follow-up data were enrolled. All IC patients had endoscopic
SUBMITTER: Sura SP
PROVIDER: S-EPMC3956001 | biostudies-literature | 2014 Apr
REPOSITORIES: biostudies-literature